Real-world Study
8
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma
AI-Assisted Medical Decision-Making
Post-marketing Safety and Efficacy Surveillance of Motherwort Injection
A Real-world Study of Inetetamab for First-line Treatment of MBC
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
Real-world Daptomycin Use in Chinese ICUs